MEDITECH empowers healthcare organizations everywhere to expand their vision of what’s possible with Expanse, the world’s most intuitive and interoperable EHR. Expanse lays the foundation for the next digital era by enabling care across delivery settings, designing cloud-based systems to drive better outcomes, and providing mobile, personalized solutions to improve efficiency for an overburdened workforce. See why thousands of healthcare organizations in 23 countries choose Expanse to meet the challenges of a new era in healthcare, boosting the productivity and satisfaction of their physicians, nurses, and staff. Expand your possibilities. Visit ehr.meditech.com, find MEDITECH Podcasts on your favorite platform, videos on our YouTube channel, and follow us on Twitter, Facebook, and Instagram.
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Employing a proprietary Fast-Clear linker technology, Fusion connects alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha emitting payloads to tumors. Fusion's lead program, FPI-1434, is currently in a Phase 1 clinical trial.
Fusion is headquartered in Hamilton, ON, with offices in Boston, MA.
Pharmatech, Inc. is a Site Management Organization (SMO) that specializes in creating efficiencies in the clinical trial process. Through an organized network of clinics, the Company focuses on advancing the development of products for a broad range of pharmaceutical and biotechnology companies, and on promoting the inclusion of clinical trials in the spectrum of patient treatment options.